Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Trial Status: closed to accrual

This phase II trial studies the effect of cetuximab in treating patients with chordoma that has spread from its original site of growth to distant anatomic sites and is not amenable to surgical resection (advanced unresectable) or has spread to other parts of the body (metastatic). Cetuximab may interfere with the epidermal growth factor receptor (EGFR) gene, which may cause tumor cells to die.